A study published in JAMA Network, by the Case Western Reserve University examined about 15,11,637 eligible participants with ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.

A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments like Ozempic and Wegovy, often triggers a rapid return of lost pounds.

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.

I f you're a FuturHealth member, you'll now have a free membership to Apple Fitness Plus as part of your program. It's Apple ...

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Ozempic has, in the recent times, become popular for weight loss, but new research hints it may hamper muscle strength, even ...

As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...

To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.

Ozempic’s weight loss benefits might come at the cost of muscle strength, even if muscle size remains relatively stable. This ...